Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Jul 31, 2019 7:46pm
93 Views
Post# 29981840

RE:RE:RE:Meticulous planning

RE:RE:RE:Meticulous planning
skier59 wrote: Yup that would be the best business plan for existing Shareholders. 

robertshaw wrote:
security01 wrote: This whole PP debacle kind of makes a mockery of the managements meticulous planning that Claridge / Bencro trots out on a regular basis .
Was this meticulously planned for them to bury their noses in the trough again or was it just plain ineptitude ?
Great news today though for patient 5 .


The best choice now is to cancel this round of prostitute party and concentrate on carrying out more phase 2 human trials on Canadian side, really not much money needed, wait for the 3 months and 6 months data out, let the brilliant science prove itself to the whole world as it showed in past 2 years. .




To think about the $hit testing technology EXAS, a kind of unproven method and without any strategy in treating cancers, yet traded over U.S $120/share, while we have the revolutionary technology of only 1 treatment then cured dying patients with astonishing 18 months+ cancer free news, barely over 30 cents , I just wondered why the company management just wants to sell the technology so damn dirty cheap to shameless agencies?
Bullboard Posts